These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19328753)

  • 21. 3D PLLA/ibuprofen composite scaffolds obtained by a supercritical fluids assisted process.
    Cardea S; Baldino L; Scognamiglio M; Reverchon E
    J Mater Sci Mater Med; 2014 Apr; 25(4):989-98. PubMed ID: 24366467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supercritical CO2 fluid-foaming of polymers to increase porosity: a method to improve the mechanical and biocompatibility characteristics for use as a potential alternative to allografts in impaction bone grafting?
    Tayton E; Purcell M; Aarvold A; Smith JO; Kalra S; Briscoe A; Shakesheff K; Howdle SM; Dunlop DG; Oreffo RO
    Acta Biomater; 2012 May; 8(5):1918-27. PubMed ID: 22307029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrospun composite poly(L-lactic acid)/tricalcium phosphate scaffolds induce proliferation and osteogenic differentiation of human adipose-derived stem cells.
    McCullen SD; Zhu Y; Bernacki SH; Narayan RJ; Pourdeyhimi B; Gorga RE; Loboa EG
    Biomed Mater; 2009 Jun; 4(3):035002. PubMed ID: 19390143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
    Shaheen SM; Takezoe K; Yamaura K
    Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth factors delivery from hybrid PCL-starch scaffolds processed using supercritical fluid technology.
    Diaz-Gomez L; Concheiro A; Alvarez-Lorenzo C; García-González CA
    Carbohydr Polym; 2016 May; 142():282-92. PubMed ID: 26917401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodegradable HA-PLA 3-D porous scaffolds: effect of nano-sized filler content on scaffold properties.
    Kothapalli CR; Shaw MT; Wei M
    Acta Biomater; 2005 Nov; 1(6):653-62. PubMed ID: 16701846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of hydrophilic drug from biodegradable polymer blends.
    Tan LP; Hidayat A; Lao LL; Quah LF
    J Biomater Sci Polym Ed; 2009; 20(10):1381-92. PubMed ID: 19622278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Porous poly(DL-lactic acid) matrix film with antimicrobial activities for wound dressing application.
    Chitrattha S; Phaechamud T
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():1122-30. PubMed ID: 26478412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porous poly(D,L-lactic acid) foams with tunable structure and mechanical anisotropy prepared by supercritical carbon dioxide.
    Floren M; Spilimbergo S; Motta A; Migliaresi C
    J Biomed Mater Res B Appl Biomater; 2011 Nov; 99(2):338-49. PubMed ID: 21953772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabrication of three-dimensional porous scaffolds of complicated shape for tissue engineering. I. Compression molding based on flexible-rigid combined mold.
    Wu L; Zhang H; Zhang J; Ding J
    Tissue Eng; 2005; 11(7-8):1105-14. PubMed ID: 16144446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of mechanical and biological properties of porous CaSiO3 scaffolds by poly(D,L-lactic acid) modification.
    Wu C; Ramaswamy Y; Boughton P; Zreiqat H
    Acta Biomater; 2008 Mar; 4(2):343-53. PubMed ID: 17921076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoinductive fibrous scaffolds of biopolymer/mesoporous bioactive glass nanocarriers with excellent bioactivity and long-term delivery of osteogenic drug.
    El-Fiqi A; Kim JH; Kim HW
    ACS Appl Mater Interfaces; 2015 Jan; 7(2):1140-52. PubMed ID: 25531645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic mechanical behavior of starch-based scaffolds in dry and physiologically simulated conditions: effect of porosity and pore size.
    Ghosh S; Gutierrez V; Fernández C; Rodriguez-Perez MA; Viana JC; Reis RL; Mano JF
    Acta Biomater; 2008 Jul; 4(4):950-9. PubMed ID: 18331817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabrication, characterization, and in vitro evaluation of poly(lactic acid glycolic acid)/nano-hydroxyapatite composite microsphere-based scaffolds for bone tissue engineering in rotating bioreactors.
    Lv Q; Nair L; Laurencin CT
    J Biomed Mater Res A; 2009 Dec; 91(3):679-91. PubMed ID: 19030184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scaffold for tissue engineering fabricated by non-isothermal supercritical carbon dioxide foaming of a highly crystalline polyester.
    Gualandi C; White LJ; Chen L; Gross RA; Shakesheff KM; Howdle SM; Scandola M
    Acta Biomater; 2010 Jan; 6(1):130-6. PubMed ID: 19619678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents.
    Balmayor ER; Tuzlakoglu K; Marques AP; Azevedo HS; Reis RL
    J Mater Sci Mater Med; 2008 Apr; 19(4):1617-23. PubMed ID: 18214645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled graft copolymerization of lactic acid onto starch in a supercritical carbon dioxide medium.
    Salimi K; Yilmaz M; Rzayev ZMO; Piskin E
    Carbohydr Polym; 2014 Dec; 114():149-156. PubMed ID: 25263875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A one-pot method to enhance dissolution rate of low solubility drug molecules using dispersion polymerization in supercritical carbon dioxide.
    Galia A; Scialdone O; Filardo G; Spanò T
    Int J Pharm; 2009 Jul; 377(1-2):60-9. PubMed ID: 19439168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preparation of porous polylactic-acid/ bone matrix gelatin composite as scaffold materials for bone-tissue engineering].
    Zhang YM; Li BX; Li J; Ma HQ; Zhao YP; Yuan L
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1745-8. PubMed ID: 17259111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.